Gel shift assays using recombinant MvaT and LUZ24 gp4 proved an inhibitory effect of LUZ24 gp4 on MvaT DNA binding activity, potentially enabling this AT-rich phage to escape bacterial transcriptional silencing and proceed to complete its lytic infection cycle. Here, CD36 is linked to infection.